NCT04108780 is a clinical trial of T-tube in CBD Exploration, sponsored by Assiut University.

Who is sponsoring NCT04108780?

NCT04108780 is sponsored by Assiut University.

What drugs are being tested in NCT04108780?

Interventions in NCT04108780: T-tube.

What condition does NCT04108780 study?

NCT04108780 studies CBD Exploration.

Is NCT04108780 still recruiting?

NCT04108780 is currently status unknown. Last updated 30 September 2019.

Last reviewed 2019-09-30 · How we verify

NCT04108780

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CBD Repair Over T-tube or Primary Repair

Status unknown Last updated 30 September 2019

What this trial tests

trial testing T-tube in CBD Exploration in 30 participants. Status unknown.

Timeline

25 September 2019

Primary endpoint
30 March 2022

30 July 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	25 September 2019
Primary completion	30 March 2022
Estimated completion	30 July 2022

Drugs / interventions tested

T-tube

Conditions studied

CBD Exploration — all drugs for CBD Exploration →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with CBD Exploration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim is to assess the benefits and harms of T-tube drainage versus primary closure without biliary stent after exploration common bile duct stones

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04108780 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 30 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04108780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing